Document Details
Form
Filing Date
Nov 13, 2017
Document Date
Nov 13, 2017
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.